Thursday, October 16, 2014

Technology on Veterinary Medicine

New Technology in Castration



European Technology in Veterinary Medicine – On its Way

ImproVac – the only vaccine to reduce boar tint.

“The way is open for EU swine producers to raise male pigs intact, with improved feed conversion and carcass quality compared to castrates, while still reducing boar taint as effectively as castration” says Jim Allison, Technical Director Swine, Pfizer Animal Health: Europe.

This technology is already approved in over 50 countries. The development of a vaccine to control boar taint actually began life in Australia some 20 years ago which the project nearly ended in 1933 when it was decided that it may not be worth spending more time and money which is about to disappear forever. However, Dr David Hennessy, Australia’s State Government Research Facilities, Victorian Institute of Animal Science conduct a small trial on the vaccine and it was successful and the development programme continued. Because of his background in pig production, Hennessy had seen the potential of the Technology as a way of avoiding the losses associated with castration while keeping the highest standards and still reducing boar tint.

The idea behind the vaccine is to encourage the pig’s immune system to produce antibodies which inhibit the function of the testicles and thus reduce the level of boar taint compounds in the meat.
                                                                                                                                        
Normally, gonadotrophin releasing factor (GnRF) which is released by the pig’s brain and starts to stimulate the release of steroids (terstosterone and androstenone-a major cause of boar tint) from the testicles as the pigs reaches puberty. Injection of ImproVac will stopped the action of the GnRF that eventually antagonize the build-up of boar taint compounds that is frequently found in the meat thereby unnecessary odour or smell of the meat is minimize or absent.

In 1998, the world’s first vaccine for the reduction of boar tint in male pigs was finally licensed in Australia and is now making an impact on a global scale.


On this developed technology, vaccination against boar tint has not been an overnight sensation, it many years to developed and has accumulated over ten years of commercial experience in over 10 million pigs.